Pacific Biosciences of California Inc (PACB)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$2.05
Buy
$2.06
$-0.065 (-3.07%)
Prices updated at 16 Dec 2025, 15:25 EST
| Prices minimum 15 mins delay
Prices in USD
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 201m | 154m | |
| 53m | 37m | |
| -310m | -291m | |
| -154.78 | -188.73 | |
| -307m | -310m | |
| -277m | -243m | |
| Sales, General and administrative | 170m | 175m |
| Interest expenses | 14m | 13m |
| Provision for income taxes | -11m | 316,000 |
| Operating expenses | 363m | 328m |
| Income before taxes | -318m | -310m |
| Net income available to common shareholders | -307m | -310m |
| -1.21 | -1.13 | |
| Net interest income | -14m | -13m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -1.21 | -1.59 |
| Free cash flow per share | -1.1262 | -0.8855 |
| Book value/share | 2.8525 | 1.539 |
| Debt equity ratio | 1.31733 | 1.307572 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 742m | 496m |
| Current liabilities | 95m | 66m |
| Total capital | 1,594m | 1,154m |
| Total debt | 934m | 672m |
| Total equity | 701m | 507m |
| Total non current liabilities | - | - |
| Loans | 892m | 647m |
| Total assets | 1,746m | 1,260m |
| Total liabilities | - | - |
| Cash and cash equivalents | 180m | 55m |
| Common stock | 268m | 294m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 328m | 183m |
| Cash dividends paid | - | - |
| -268m | -212m | |
| Investments (gains) losses | 5m | 124m |
| 180m | 55m | |
| Net income | - | - |
| -259m | -206m | |
| -9m | -6m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
